| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.6M | -53.3% | -60.6% |
| Cost of Revenue | $4.8M | -48.1% | -58.2% |
| Gross Profit | $1.8M | -63.2% | -66.0% |
| R&D Expense | $623K | +16.2% | -45.7% |
| SG&A Expense | $4.2M | +16.9% | -27.1% |
| Operating Income | -$3.0M | -476.2% | -89.7% |
| Net Income | -$3.2M | -628.3% | -63.7% |
| EPS (Basic) | -$0.15 | -600.0% | -25.0% |
| EPS (Diluted) | -$0.15 | -600.0% | -25.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $3.9M | -54.6% | -60.8% |
| Inventory | $16.7M | +6.1% | +1.4% |
| Current Assets | $23.4M | -15.2% | -14.3% |
| Total Assets | $25.6M | -15.0% | -16.2% |
| Current Liabilities | $20.6M | -6.9% | -39.8% |
| Total Liabilities | $21.0M | -7.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.7M | — | — |
| Capital Expenditures | $405K | — | — |
| Investing Cash Flow | -$405K | — | — |
| Financing Cash Flow | $5.1M | — | — |
| Free Cash Flow | -$6.1M | — | — |
| -39.9% |
| Stockholders' Equity | $4.6M | -38.8% | +205.5% |